Provided by Tiger Trade Technology Pte. Ltd.

BAIYUNSHAN PH

13.310
-0.120-0.89%
Volume:1.77M
Turnover:23.57M
Market Cap:21.64B
PE:6.20
High:13.390
Open:13.390
Low:13.270
Close:13.430
52wk High:19.218
52wk Low:13.270
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:1.49
T/O Rate:0.80%
Dividend:0.86
Dividend Rate:6.48%
EPS(LYR):2.145
ROE:6.50%
ROA:2.09%
PB:0.47
PE(LYR):6.20
PS:0.24

Loading ...

BAIYUNSHAN PH Issues Supplemental Disclosure to 2025 Annual Report, Confirms Chapter 14A Compliance

Bulletin Express
·
Sep 10

Baiyunshan PH Posts Flat Revenue, Lower Profit in H1 2026; Declares RMB0.30 Interim Dividend

Bulletin Express
·
Sep 08

Baiyunshan Announces Cash Dividend Distribution for First Half of 2026

Deep News
·
Sep 03

Baiyunshan Pharma Reports Stable Share Structure in August 2026 Monthly Return

Bulletin Express
·
Sep 01

Guangzhou Baiyunshan Pharmaceutical - Disposal of First New Underlying Assets of Gp Corp. to Industrial Securities Asset Management for Rmb146.3 Mln

THOMSON REUTERS
·
Aug 28

Baiyunshan's First-Half Profit Plunges 16.7%: Herbal Tea Business Under Pressure, Lingering Legal Battle Over Jinge Resurfaces

Deep News
·
Aug 28

Huawei Plans for More AI Pharma Tie-Ups, Says Healthcare President

Reuters
·
Aug 27

GPHL Hosts Global Investment Conference in Singapore, Launches WALOVI International Headquarters

Deep News
·
Aug 24

BAIYUNSHAN PH Gets Nod for Norepinephrine Bitartrate Injection Consistency Assessment

Stock News
·
Aug 24

Hong Kong Stock Flash | Baiyunshan (00874) Drops Nearly 6% After Results, Net Profit Falls 16.7% in H1 Due to Higher R&D Spending

Stock News
·
Aug 24

Guangzhou Baiyunshan Pharma's Profit Falls 17% in H1

MT Newswires Live
·
Aug 24

BAIYUNSHAN PH Reports Interim Results with Net Profit Attributable to Shareholders of Approximately RMB 2.096 Billion, Down 16.7% Year-on-Year

Stock News
·
Aug 21

Guangzhou Baiyunshan Unit Secures Australian TGA Recertification, Reinforcing Global Quality Standards

Deep News
·
Aug 20

Baiyunshan Pharmaceutical Subsidiary Gets China Supplementary Drug Nod for Brain Injury Injection

MT Newswires Live
·
Aug 20

BAIYUNSHAN PH Secures Regulatory Approval for Citicoline Sodium Injection New Dosage Strengths

Stock News
·
Aug 19

Baiyunshan Pharmaceutical's Unit Gets Macao Drug Regulator's Nod for Cefazolin Sodium for Injection

MT Newswires Live
·
Aug 18

BAIYUNSHAN PH Subsidiary Secures Pharmaceutical Registration Certificate from Macau Health Regulator

Stock News
·
Aug 17

Earning Preview: BAIYUNSHAN PH EPS expected to decline 4.44% YoY, institutional commentary remains muted

Earnings Agent
·
Aug 15

Baiyunshan Launches Sugar-Free Gold Edition Banlangen Granules

Deep News
·
Aug 13

Baiyunshan Pharmaceutical Gets Nod to Trial New Indication for Zhangyanming Tablets

MT Newswires Live
·
Aug 11